April 2008

Acquired 100% of Nanjing Xinaokang Pharmaceutical Limited

March 2008

Joint Venture with leading US contract research service provider, XenoBiotic Laboratories, Inc.

December 2007

Appointed distributor in China for Meiji Seika’s best selling new generation anti-biotics, “Meiact”

Appointed exclusive distributor in China for a cough syrup named Pholcotussin, manufactured by Europharm, a leading Hong Kong pharmaceutical company

October 2007

Selected as one of the 50 constituents in the FTSE ST China Index and one of the 195 constituents for the new FTSE ST Small Cap Index

Tripled freeze-drying capacity to 18 million units per annum

August 2007

Strategic alliance with Nasdaq-listed Optimer Pharmaceuticals, Inc

June 2007

Appointed exclusive distributor in China by Pharmco for its Century series, leading multivitamin supplements in US

April 2007

Placement of shares to CMIA to fund expansion of R&D, distribution and marketing activities

July 2006

Acquired 100% of Shenzhen Liancheng Medicine Company Limited

February 2006

Acquired 69.98% of Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd

October 2005

Listed on the Mainboard of Singapore Exchange